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Response to Letter by D’Anna et al  
Regarding  Article, “Long-Term Mortality 
in Patients With Stroke of Undetermined 
Etiology”
Response:
We appreciate the interest of Dr D’Anna and colleagues 
in our recently published article.1 Dr D’Anna and colleagues 
raised a question about the definition of incomplete evalua-
tion. They argued that echocardiography should be a routine 
and essential evaluation for stroke patients. Dr D’Anna and 
colleagues mentioned that Adams et al2 recommended not to 
classify study patients in a defined category (the cardioembolic 
one in this case) without performing essential diagnostic tests. 
However, we cannot find any description that a patient should 
not be classified in a defined category without echocardiogra-
phy. Dr Adams stated that, “Diagnoses are based on clinical 
features and on data collected by tests such as brain imaging 
(CT/MRI), cardiac imaging (echocardiography, etc.), duplex 
imaging of extracranial arteries, arteriography, and laboratory 
assessments for a prothrombotic state. ..... we cannot require 
that all patients have all diagnostic tests...... To compensate for 
this situation, the Trial of Org 10172 in Acute Stroke Treatment 
(TOAST) system allows for a ‘possible’ stroke subtype diag-
nosis.” Although we agree with Dr D’Anna and colleagues that 
physicians should make every effort to find potential causes 
of stroke, cardiac imagings may not be performed because of 
several reasons in some patients. In many cases, diagnosis of 
cardioembolism can be made without echocardiographic stud-
ies. For example, in a case with atrial fibrillation, which is the 
most common potential cardiac source of embolism,3 we can 
classify a patient as cardioembolism without echocardiography. 
We do not think that such a patient should be classified as an 
incomplete evaluation simply because of a lack of an echocar-
diography. This patient even can be classified as a possible car-
dioembolism without angiographic studies.
Although Dr D’Anna and colleagues did not specifiy which 
echocardiography should be essential, the yield for diagnosis of 
potential cardiac source of embolism is quite different between 
transthoracic echocardiography and transesophageal echocar-
diography. The diagnostic yield of transthoracic echocardiog-
raphy in stroke patients with no history of cardiac disease is 
much lower than transesophageal echocardiography.4 Therefore, 
transesophageal echocardiography is the modality of choice in 
patients with unexplained stroke when clinical heart disease 
is absent.4 However, transesophageal echocardiography can-
not be performed in many patients because of several reasons.5 
Therefore, it seems inappropriate that we classify all patients 
who had not undergone echocardiography into an incomplete 
evaluation.
Dr D’Anna and colleagues also questioned why 13.5% of 
patients with cardioembolism did not receive at least an ultra-
sound study. They were classified as cardioembolism because 
we aggregated probable and possible categories into the 1 
stroke subtype based on the TOAST classification (they were 
classified as possible cardioembolism). We do not have an 
exact answer why angiographic or ultrasound studies were not 
performed in them because our study was performed retrospec-
tively. However, in general, a carotid Doppler has been less 
frequently used for stroke evaluation in our institution because 
intracranial atherosclerosis is more common than extracranial 
atherosclerosis in Asian patients and a carotid Doppler alone is 
not good enough for evaluation of entire cerebral arteries.
Dr D’Anna and colleagues suggested that the setting of 
care should be considered as a confounding factor because 
admission to an organized stroke care has a positive effect 
on outcomes. This comment is pertinent. We reanalyzed 
our data. Among the 3278 patients, 1653 patients (50.4%) 
were admitted to the stroke unit (SU). Rate of admission to 
the SU was lower in patients with an incomplete evaluation 
than those with other stroke subtypes (14.6% versus 52.2%, 
P<0.001). However, in the univariate analysis, SU care was 
not related with long-term mortality (odds ratio, 0.90; 95% CI, 
0.77–1.06). In multivariate analysis, which included SU care 
as a confounding factor, the incomplete evaluation still showed 
higher odds ratio (odds ratio, 2.54; 95% CI, 1.64–3.94). The 
reason why the SU care was not associated with favorable out-
comes is uncertain. Our study was conducted for patients who 
were admitted between July 1997 and June 2007, whereas our 
SU was opened at December 2002. Thus, the benefit of the 
SU might be reduced by this time effect. We further investi-
gated whether an incomplete evaluation was associated with 
worse prognosis after excluding SU-related factors by analyz-
ing data in the population who were admitted before the SU 
opened. Multivariate analysis revealed that the patients with 
an incomplete evaluation in this population still showed high 
long-term mortality (odds ratio, 2.00; 95% CI, 1.12–3.57). Our 
reanalyses indicated that SU care was not a contributing fac-
tor for high long-term mortality in patients with an incomplete 
evaluation.
The last opinion of Dr D’Anna and colleagues was that, 
instead of using small vessel disease as a reference in the 
multivariate analysis, comparison between determined and 
undetermined etiology could be more useful to investigate 
the effects of a stroke diagnostic assessment on prognosis. 
However, the etiologic mechanism of undetermined etiology 
in the TOAST classification is very heterogeneous in that the 
undetermined etiology includes not only incomplete evaluation 
but also negative evaluation despite extensive work-up and 
multiple causes identified. Therefore, simple dichotomization 
of the subtypes into determined and undetermined does not 
provide accurate information that represents prognosis in each 
subtype. In addition, we believe that most physicians are familiar 
with predicting prognosis based on each stroke subtype (for 
instance, prognosis is good in small artery disease but poor in 
cardioembolism).
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